Tenascin-C in primary Merkel cell carcinoma

被引:13
作者
Koljonen, V
Jahkola, T
Tukiainen, E
Granroth, G
Haglund, C
Böhling, T
机构
[1] Helsinki Univ Hosp, Dept Plast Surg, Helsinki 00029, HUS, Finland
[2] Univ Helsinki, Dept Pathol, Helsinki 00029, HUS, Finland
[3] HUSLAB, Helsinki 00029, HUS, Finland
[4] Vaasa Cent Hosp, Dept Pathol, Vaasa 651000, Finland
关键词
D O I
10.1136/jcp.2004.018432
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background/Aims: Merkel cell carcinoma (MCC) is a rare malignant cutaneous neuroendocrine tumour that mostly affects the elderly. It shows rapid progression of the primary tumour, together with a vertical growth pattern into the underlying subcutaneous tissue. Metastatic dissemination to regional lymph nodes is early and frequent. Tenascin-C (Tn-C) is a large extracellular matrix glycoprotein that is expressed in various benign and malignant processes. Expression of Tn-C is also associated with invasion and cellular proliferation, and is often downregulated in fully evolved advanced carcinomas. In previous studies, Tn-C expression correlated with prognosis in tumours of different origin. Methods: Immunohistochemistry was used to investigate the expression of Tn-C in 25 MCC specimens and to evaluate the prognostic importance of this glycoprotein. Results: Seventeen samples expressed Tn-C. Staining was mainly seen in the invasion borders and within the connective tissue septae inside the tumours. The expression of Tn-C correlated significantly with large tumour size. There was also frequent expression of Tn-C in primary tumours with metastatic dissemination. Most of the Tn-C negative samples were of small size. Conclusions: Tn-C expression seems to increase with tumour size and malignant behaviour. Expression was slightly enhanced in tumours with high proliferative indices. Expression is seen mainly in areas of invasive growth and, in this respect, resembles that of other invasive tumours.
引用
收藏
页码:297 / 300
页数:4
相关论文
共 34 条
[1]  
ADAMS JC, 1993, DEVELOPMENT, V117, P1183
[2]  
Atula T, 2003, ANTICANCER RES, V23, P3051
[3]  
BOURDON MA, 1983, CANCER RES, V43, P2796
[4]   FURTHER INSIGHTS INTO THE NATURAL-HISTORY AND MANAGEMENT OF PRIMARY CUTANEOUS NEUROENDOCRINE (MERKEL CELL) CARCINOMA [J].
BOYLE, F ;
PENDLEBURY, S ;
BELL, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (02) :315-323
[5]   THE COLLAGEN SUPERFAMILY [J].
BROWM, JC ;
TIMPL, R .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (04) :484-490
[6]   Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor [J].
Byrd-Gloster, AL ;
Khoor, A ;
Glass, LF ;
Messina, JL ;
Whitsett, JA ;
Livingston, SK ;
Cagle, PT .
HUMAN PATHOLOGY, 2000, 31 (01) :58-62
[7]   INCIDENCE OF CUTANEOUS T-CELL LYMPHOMA AND OTHER RARE SKIN CANCERS IN A DEFINED POPULATION [J].
CHUANG, TY ;
SU, WPD ;
MULLER, SA .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 23 (02) :254-256
[8]   TENASCIN - AN EXTRACELLULAR-MATRIX PROTEIN PROMINENT IN SPECIALIZED EMBRYONIC-TISSUES AND TUMORS [J].
ERICKSON, HP ;
BOURDON, MA .
ANNUAL REVIEW OF CELL BIOLOGY, 1989, 5 :71-92
[9]  
Goepel C, 2003, ANTICANCER RES, V23, P4587
[10]   Clinical impact and functional aspects of tenascin-C expression during glioma progression [J].
Herold-Mende, C ;
Mueller, MM ;
Bonsanto, MM ;
Schmitt, HP ;
Kunze, S ;
Steiner, HH .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (03) :362-369